Novo Nordisk A/S NOVO B.CO · DKK

Its shares trade on Nasdaq Copenhagen under the ticker NOVO B.CO. It has been listed since 17 May 1974. In the fiscal year to 31 December 2025, it reported revenue of DKK 309.06bn and net income of DKK 102.43bn. At that date it held total assets of DKK 542.90bn and shareholders' equity of DKK 194.05bn.

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Helge LundIndependent Chairman of the BoardDKK 4.3m
• Mr. Maziar DoustdarPresident, Chief Executive Officer
• Mr. Henrik PoulsenVice Chairman of the Board, since 2021DKK 2.6m
• Mr. Karsten Munk KnudsenChief Financial Officer, Executive Vice PresidentDKK 26.8m
• Dr. Martin LangeExecutive Vice President, Chief Scientific Officer, Research & DevelopmentDKK 23.4m
• Ms. Thilde BogebjergExecutive Vice President - Quality, IT & Environmental Affairs
• Mr. Ludovic HelfgottExecutive Vice President - Product & Portfolio Strategy
• Mr. Emil LarsenExecutive Vice President - International Operations
• Mr. David MooreExecutive Vice President - US Operations and Business Development
• Ms. Tania SabroeExecutive Vice President - People, Organisation & Corporate Affairs
• Mr. Henrik WulffExecutive Vice President - Product SupplyDKK 25.9m
• Ms. Mette Boejer JensenDirector, Employee RepresentativeDKK 1.3m

Overall

71

Environment

69

Social

90

Governance

54

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.